Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v6-EN
Language English English
Date Updated 2024-08-07 2024-08-06
Drug Identification Number 02460955 02460955
Brand name CASPOFUNGIN FOR INJECTION CASPOFUNGIN FOR INJECTION
Common or Proper name Caspofungin Acetate for Injection Caspofungin Acetate for Injection
Company Name JUNO PHARMACEUTICALS CORP. JUNO PHARMACEUTICALS CORP.
Ingredients CASPOFUNGIN CASPOFUNGIN
Strength(s) 70MG 70MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 70 mg/vial - 1 vial per carton 70 mg/vial - 1 vial per carton
ATC code J02AX J02AX
ATC description ANTIMYCOTICS FOR SYSTEMIC USE ANTIMYCOTICS FOR SYSTEMIC USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2024-06-14 2024-06-14
Actual start date 2024-06-14 2024-06-14
Estimated end date 2024-08-31 2024-08-31
Actual end date 2024-08-06 2024-08-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Delays in QC testing schedules Delays in QC testing schedules
Health Canada comments